Feb. 16, 2024, 12:18 p.m. |

Bloomberg Technology bloomberg.com

Novartis CEO Vas Narasimhan talks about acquisitions, AI and the future of weight-loss drugs. He speaks on "The David Rubenstein Show: Peer-to-Peer Conversations." This interview was recorded Feb. 15 in New York. (Source: Bloomberg)

acquisitions bloomberg ceo conversations david drugs future interview loss novartis peer peer-to-peer show talks weight-loss

Artificial Intelligence – Bioinformatic Expert

@ University of Texas Medical Branch | Galveston, TX

Lead Developer (AI)

@ Cere Network | San Francisco, US

Research Engineer

@ Allora Labs | Remote

Ecosystem Manager

@ Allora Labs | Remote

Founding AI Engineer, Agents

@ Occam AI | New York

AI Engineer Intern, Agents

@ Occam AI | US